Researchers have come up with a new drug that can stop migraines before they start.
The antibody, Erenumab, works by blocking a neural brain pathway called CGRP.
According to Daily Star, the drug has been tested on around 1,000 patients and results have been very promising.
Typically, the antidote was able to prevent three and four “migraine days” every month. Data also showed that the duration of the throbbing headaches was cut in half.
Globally, more than 127 million people are migraine sufferers.
Migraine typically results in symptoms of pulsating pain, nausea and sensitivity to light and noise. It can also prevent sufferers from carrying out everyday tasks, which sometimes leads to depression.